These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4427229)

  • 1. Distribution of 14C-lomustine (14C-CCNU)-derived radioactivity following intravenous administration of three potential clinical formulations to rabbits.
    Litterst CL; Mimnaugh EG; Cowles AC; Gram TE; Guarino AM
    J Pharm Sci; 1974 Nov; 63(11):1718-21. PubMed ID: 4427229
    [No Abstract]   [Full Text] [Related]  

  • 2. Fat emulsion vehicle for intravenous administration of an aqueous insoluble drug.
    Fortner CL; Grove WR; Bowie D; Walker MD
    Am J Hosp Pharm; 1975 Jun; 32(6):582-4. PubMed ID: 1155469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodistribution of 14C-lomustine in an animal tumor model.
    Castronovo FP; Potsaid MS; Kopiwoda SY
    J Pharm Sci; 1980 Jan; 69(1):87-9. PubMed ID: 7354451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential distribution and covalent binding of two labeled forms of methyl-CCNU in the Fischer 344 rat.
    Kramer RA; McMenamin MG; Boyd MR
    Cancer Chemother Pharmacol; 1985; 14(2):150-5. PubMed ID: 3971479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation of three nitrosoureas for intravenous use.
    Davignon JP; Yang KW; Wood HB; Cradock JC
    Cancer Chemother Rep 3; 1973 May; 4(3):7-11. PubMed ID: 4201309
    [No Abstract]   [Full Text] [Related]  

  • 6. Physiologic disposition of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (Me CCNU) in man.
    Sponzo RW; DeVita VT; Oliverio VT
    Cancer; 1973 May; 31(5):1154-6. PubMed ID: 4705152
    [No Abstract]   [Full Text] [Related]  

  • 7. Distribution of radiolabeled 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitros ourea hydrochloride in rat brain tumor: intraarterial versus intravenous administration.
    Yamada K; Ushio Y; Hayakawa T; Arita N; Huang TY; Nagatani M; Yamada N; Mogami H
    Cancer Res; 1987 Apr; 47(8):2123-8. PubMed ID: 3470138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of RNA synthesis in murine ependymoblastoma by the combination of amphotericin B and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Laurent G; Dewerie-Vanhouche J; Machin D; Hildebrand J
    Cancer Res; 1980 Mar; 40(3):939-42. PubMed ID: 7471107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The binding of 14C labelled 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) to macromolecules of sensitive and resistant tumours.
    Connors TA; Hare JR
    Br J Cancer; 1974 Nov; 30(5):477-80. PubMed ID: 4469198
    [No Abstract]   [Full Text] [Related]  

  • 10. Formulation and biological distribution of radiolabeled 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in an animal tumor model.
    Castronovo FP; Potsaid MS; Kopiwoda S
    Cancer Res; 1980 Oct; 40(10):3473-4. PubMed ID: 7438035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the tissue-disposition and fate of N-[14C]ethyl-N-nitrosourea in mice.
    Johansson-Brittebo E; Tjälve H
    Toxicology; 1979 Aug; 13(3):275-85. PubMed ID: 230616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.
    Lee FY; Workman P
    Br J Cancer; 1983 May; 47(5):659-69. PubMed ID: 6849803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active site specific inactivation of chymotrypsin by cyclohexyl isocyanate formed during degradation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Babson JR; Reed DJ; Sinkey MA
    Biochemistry; 1977 Apr; 16(8):1584-9. PubMed ID: 856251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of magnetic emulsion as a novel drug carrier for chemotherapeutic agents.
    Akimoto M; Morimoto Y
    Biomaterials; 1983 Jan; 4(1):49-51. PubMed ID: 6838956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition and metabolism in 1-(2-chloroethyl)-3-(2',3',4'-tri-o-acetyl, ribopyranosyl)-1-nitrosourea in rats.
    Godeneche D; Moreau MF; Madelmont JC; Duprat J; Plagne R
    Cancer Res; 1982 Feb; 42(2):525-9. PubMed ID: 6799188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of uptake of nitrosoureas by L5178Y lymphoblasts in vitro.
    Begleiter A; Lam HP; Goldenberg GJ
    Cancer Res; 1977 Apr; 37(4):1022-7. PubMed ID: 557367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 5-azacytidine (NSC-102816) with CCNU (NSC-79037) in the treatment of patients with breast cancer and evaluation of the subsequent use of cyclophosphamide (NSC-26271).
    Cunningham TJ; Nemoto T; Rosner D; Knight E; Taylor S; Rosenbaum C; Horton J; Dao T
    Cancer Chemother Rep; 1974; 58(5 Pt 1):677-81. PubMed ID: 4138966
    [No Abstract]   [Full Text] [Related]  

  • 19. Disposition of the carcinostatic agent 1-(2-chloroethyl)-3-[1'-(5'-p-nitrobenzoyl-2',3'-isopropylidene)-alpha,beta-d-ribofuranosyl]-1-nitrosourea in animals.
    Godenèche D; Madelmont JC; Moreau MF; Montoloy D; Plagne R
    Cancer Res; 1980 Sep; 40(9):3351-6. PubMed ID: 7427947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
    Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
    Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.